WAY-270360

CAS No. 476633-98-4

WAY-270360( N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide )

Catalog No. M28522 CAS No. 476633-98-4

WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 135 In Stock
10MG 188 In Stock
25MG 332 In Stock
50MG 456 In Stock
100MG 642 In Stock
200MG Get Quote In Stock
500MG 1274 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-270360
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
  • Description
    WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    476633-98-4
  • Formula Weight
    373.412
  • Molecular Formula
    C22H19N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc(C(=O)Nc2ccc(cc2)-c2nc3ccccc3[nH]2)c(OC)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CO-1686

    A potent, highly selective, irreversible inhibitor of mutant EGFR with Ki of 21.5 nM for EGFR L858R/T790M.

  • Olmutinib

    Olmutinib is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorOlmutinib at 3 μM significantly reversed drug resistance mediated by ABCG2, but not by ABCB1 and ABCC1, by antagonizing the drug efflux function in ABCG2-overexpressing cells.?

  • BPR1J-097

    BPR1J-097 is a novel FLT-3 inhibitor(IC50: 11±7 nM) with promising in vivo anti-tumor activities. It also inhibits FLT-3 D835Y (IC50: 3 nM).